Upregulation and secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric cancers

Clin Chim Acta. 2009 Mar;401(1-2):128-33. doi: 10.1016/j.cca.2008.12.008. Epub 2008 Dec 14.

Abstract

Background: Macrophage inhibitory cytokine-1 (MIC-1), a distant member of the transforming growth factor (TGF)-beta superfamily, has been reported to be upregulated and secreted from several cancers. We examined MIC-1 expression and secretion in gastric cancers.

Methods: MIC-1 mRNA and protein levels in cancer tissues and cell lines were analyzed by RT-PCR and Western blot. MIC-1 expression in cancer tissues and its secretion in serum were analyzed using immunohistochemistry and ELISA.

Results: MIC-1 was significantly upregulated in gastric cancer tissues and cell lines. MIC-1 was secreted from gastric SNU620 cells and its levels in the serum of cancer patients were 10-fold higher than those of healthy controls. In addition, the staining of MIC-1 expression was strongly increased in metastatic gastric cancers.

Conclusions: MIC-1 was obviously overexpressed in gastric cancers and MIC-1 secretion into blood may be useful for the prediction of gastric cancer progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Biomarkers, Tumor / blood
  • Biomarkers, Tumor / metabolism*
  • Cell Line, Tumor
  • Growth Differentiation Factor 15 / blood
  • Growth Differentiation Factor 15 / metabolism*
  • Humans
  • Prognosis
  • Stomach Neoplasms / blood
  • Stomach Neoplasms / metabolism
  • Stomach Neoplasms / pathology*
  • Up-Regulation / genetics*

Substances

  • Antibodies, Monoclonal
  • Biomarkers, Tumor
  • Growth Differentiation Factor 15